Latest News

New CSO appointed: Olof Larsson, PhD

The current member of the Sinfonia board of directors, Olof Larsson, is entering the operational role as the company’s CSO. Olof is replacing Johan Lundkvist who is continuing as COO.  Olof’s prior experience as CSO for Eli Lilly Pain and Migraine...

ADPD 2022 – Recent Progress

Sinfonia will present a poster at ADPD 2022, Barcelona March 15th-20th. The company will present recent progress made within its FTDRepair project,  a novel precision therapy for progranulin related Frontotemporal lobe dementia (FTD/GRN)

New CFO: Kristofer Svensson

Sinfonia welcomes Kristofer Svensson as CFO to the company. ”We are happy to add Kristofer’s expertise to our team on our exciting journey to bring novel biotherapeutics to the market”, says Lars Wahlberg, CEO